Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115095
Chunk: 6

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 6
---
 majority of the then-outstanding SPAC Warrants approve of such amendment.”

The securities being offered in this prospectus represent a significant percentage of our outstanding Common Stock. As a result, significant near-term resale of shares of our Common Stock pursuant to this prospectus could have a significant, negative impact on the trading price of our shares of Common Stock. This impact may be heightened by the fact that, as described above, certain of the Selling Securityholders purchased shares of our Common Stock at prices that are well below the current trading price of our Common Stock. The

1,594,207 shares that may be resold into the public markets pursuant to this prospectus represent approximately 22.8% of the shares of our Common Stock outstanding as of March 31, 2025 (assuming the exercise of all outstanding SPAC Warrants for which underlying shares are registered for resale hereunder). The Selling Securityholders will be able to sell all of such shares and any SPAC Warrants registered for resale hereunder for so long as the registration statement of which this prospectus forms a part is available for use.

The sale of all the securities being offered in this prospectus could result in a significant decline in the public trading price of our securities. Despite such decline in the public trading price, some of the Selling Securityholders may still experience a positive rate of return on the securities they purchased due to the difference in the purchase prices described above. Based on the closing price of our Common Stock of $5.43 and of our Public Warrants of $0.075 per Public Warrant, in each case on May 5, 2025, the Sponsors may experience a potential profit of $5.19 per share of our Common Stock based on the Sponsor’s initial purchase price of $0.245 per share, and SCLX JV may experience a potential profit of up to $0.075 per SPAC Warrant given such warrants were acquired by SCLX JV at no cost.

No underwriter or other person has been engaged to facilitate the sale of the shares of our Common Stock or the SPAC Warrants in these offerings. The Selling Securityholders may be deemed to be “underwriters” within the meaning of the Securities Act of 1933, as amended (the “Securities Act”) of the Resale Shares and the Private Warrants that they are offering pursuant to this prospectus. We will bear all costs, expenses and fees in connection with the registration of the shares of our Common Stock and SPAC Warrants